Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.17%)
As of: Sep 4, 2026 · 2:27 PM EDT

Absci (ABSI) Receivables - Other (2023 - 2025)

Analysis

Absci (ABSI) Receivables - Other (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Absci 1.39 Bn 1.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 15.00 Mn
Jun 30, 2025 15.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 15.00 Mn
Sep 30, 2024 15.00 Mn
Jun 30, 2024 15.00 Mn
Mar 31, 2024 15.00 Mn
Dec 31, 2023 15.00 Mn
Sep 30, 2023 15.00 Mn
Jun 30, 2023 15.00 Mn
Mar 31, 2023 15.00 Mn